相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
Ling Wang et al.
CANCER CELL INTERNATIONAL (2013)
Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
Abdel-Moneim M. Osman et al.
CANCER CELL INTERNATIONAL (2013)
Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity
Min Sha et al.
CANCER CELL INTERNATIONAL (2013)
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
Kuen-Feng Chen et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
Abdel-Moneim M. Osman et al.
CANCER CELL INTERNATIONAL (2012)
Synergistic Effects of Combination Treatment with Bortezomib and Doxorubicin in Human Neuroblastoma Cell Lines
Bo-Yu Du et al.
CHEMOTHERAPY (2012)
NF-κB and the link between inflammation and cancer
Joseph A. DiDonato et al.
IMMUNOLOGICAL REVIEWS (2012)
Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling
Alfeu Zanotto-Filho et al.
INVESTIGATIONAL NEW DRUGS (2012)
α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
Dalila Naci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo
Yong-Wei Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Steven E. Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Differences in the Mechanisms of Proapoptotic BH3 Proteins Binding to Bcl-XL and Bcl-2 Quantified in Live MCF-7 Cells
Alexander Aranovich et al.
MOLECULAR CELL (2012)
Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
Azhar R. Hussain et al.
PLOS ONE (2012)
Hypoxia suppresses conversion from proliferative arrest to cellular senescence
Olga V. Leontieva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
Jing Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
Bray Denard et al.
ELIFE (2012)
Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells
Weijia Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2011)
Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model
Lili Bao et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells
Hae Sun Park et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
Dharminder Chauhan et al.
BMC BIOLOGY (2011)
Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence
Georgina Hernandez-Flores et al.
BMC CANCER (2011)
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
Radhamani Kannaiyan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
3,5-Dimethyl-H-7-Furo[3,2-g]Chromen-7-One as a Potential Anticancer Drug by Inducing p53-Dependent Apoptosis in Human Hepatoma HepG2 Cells
Jian-guo Sun et al.
CHEMOTHERAPY (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Curcumin Enhances the Efficacy of Chemotherapy by Tailoring p65NFκB-p300 Cross-talk in Favor of p53-p300 in Breast Cancer
Gouri Sankar Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Four faces of cellular senescence
Francis Rodier et al.
JOURNAL OF CELL BIOLOGY (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Correlation of NF-κB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma
Ming Yan et al.
BMC CANCER (2010)
The chemotherapeutic agent bortezomib induces the formation of stress granules
Marie-Josee Fournier et al.
CANCER CELL INTERNATIONAL (2010)
The pharmacological NFκB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation
Alfeu Zanotto-Filho et al.
CANCER LETTERS (2010)
Molecular Pathways Linking Inflammation and Cancer
A. Mantovani
CURRENT MOLECULAR MEDICINE (2010)
Cellular Senescence in the Development and Treatment of Cancer
Gabriele Saretzki
CURRENT PHARMACEUTICAL DESIGN (2010)
The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Di Chen et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Therapy-Induced Senescence in Cancer
Jonathan A. Ewald et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Cellular Senescence and Inflammation: A Noteworthy Link
George Tsirpanlis
BLOOD PURIFICATION (2009)
Treatment of Recurrent Platinum-Resistant Ovarian Cancer with Pegylated Liposomal Doxorubicin - An Evaluation of the Therapeutic Index with Special Emphasis on Cardiac Toxicity
Ilona Steppan et al.
CHEMOTHERAPY (2009)
Significance of Cellular Senescence in Aging and Cancer
Angela Grimes et al.
CANCER RESEARCH AND TREATMENT (2009)
A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome
Jinbao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Accelerated senescence: An emerging role in tumor cell response to chemotherapy and radiation
David A. Gewirtz et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Bcl-2-family proteins and hematologic malignancies: history and future prospects
John C. Reed
BLOOD (2008)
Nuclear factor-kB activation: From bench to bedside
Gautam Sethi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Mitochondrial dynamics and apoptosis
Der-Fen Suen et al.
GENES & DEVELOPMENT (2008)
MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells:: involvement of nuclear factor-κB and activator protein-1
Pablo C. Ortiz-Lazareno et al.
IMMUNOLOGY (2008)
Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze et al.
TRENDS IN CELL BIOLOGY (2008)
Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines
Cheol-Hee Choi et al.
LEUKEMIA RESEARCH (2007)
Caspase activation by anticancer drugs: The caspase storm
Zhimin Tao et al.
MOLECULAR PHARMACEUTICS (2007)
NF-κB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition
K. La Ferla-Bruehl et al.
ONCOGENE (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Irreversibility of cellular senescence: dual roles of p16(INK4a)/Rb-pathway in cell cycle control
Akiko Takahashi et al.
CELL DIVISION (2007)
Stobadine inhibits doxorubicin-induced apoptosis through a caspase-9 dependent pathway in P815 mastocytoma cells
E. Umit Bagriacik et al.
CELL BIOLOGY INTERNATIONAL (2007)
Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patients
C. Montagut et al.
ENDOCRINE-RELATED CANCER (2006)
In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline -: Involvement of caspase cascades and IκBα phosphorylation
JM Lerma-Díaz et al.
IMMUNOLOGY LETTERS (2006)
Association of activated transcription factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma
JG Izzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The intrinsic mitochondrial membrane potential of colonic carcinoma cells is linked to the probability of tumor progression
BG Heerdt et al.
CANCER RESEARCH (2005)
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms -: Intermediacy of H2O2- and p53-dependent pathways
SW Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage:: identification of two cleavage sites by microsequencing
T Vántus et al.
CELLULAR SIGNALLING (2004)
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
PY Yeh et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Suppression of human tumor cell proliferation through mitochondrial targeting
E Holmuhamedov et al.
FASEB JOURNAL (2002)
Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging
A Krtolica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Proteasome inhibitors induce caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells
C Naujokat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2000)
Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes ΔΨm loss, caspase-9 activity, and apoptosis in Jurkat cells
S Gamen et al.
EXPERIMENTAL CELL RESEARCH (2000)
分享论文
